A Phase I California Cancer Consortium Study of Blinatumomab/Lenalidomide in Relapsed/Refractory Non-Hodgkin Lymphoma: Updated Results and Immune Correlative Analyses

Autor: Othman, Tamer *, Ruel, Christopher *, Frankel, Paul *, Merleev, Alexander A. *, Luxardi, Guillaume *, Maverakis, Emanual *, Abedi, Mehrdad, Ranganathan, Raghuveer *, Zain, Jasmine, Budde, Lihua E, Mei, Matthew, Rosenberg, Aaron S, Hoeg, Rasmus T *, Costello, Caitlin, Foss, Francine M., William, Basem M., Holland, H. Kent, Villalona-Calero, Miguel *, Sharon, Elad *, Tuscano, Joseph M
Zdroj: In Blood 15 November 2022 140 Supplement 1:9446-9447
Databáze: ScienceDirect